Innovation

The Wilmington-based ReManned Project hopes to connect 10,000 Black men with mentors to help process trauma and find success in their work and personal lives.

The Philly District Attorney’s office has begun diverting young people into an after-school arts program for a chance to expunge their records.

Of the students who made it through four years at Parkway Middle College, 95% are graduating with both a high school diploma and an associate’s degree.

Artists, once hesitant to bring strangers into their studios, now agree to do POST via digital tools.

About 40,000 babies are born with heart defects annually. The FDA approved a procedure less invasive than the surgery many get during their lives.

Doctors hope the one-time treatment, which involves permanently altering DNA in blood cells with a tool called CRISPR, may treat and possibly cure sickle cell disease.

PBS Newshour's John Yang reflects on his experience participating in Moderna's vaccine trial. "It started off with self-interest — I wanted to get the vaccine sooner."

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 in a study.

Dr. Anthony Fauci tells NPR that strong testing results for both Moderna and Pfizer vaccines are "a very, very important advance" in trying to stop the coronavirus outbreak.

COVID-19 has shown how our cities and spaces can fail to keep us healthy. But for the 15% of the population living with a disability, this awareness came before the pandemic.

Pennsylvania and Delaware have released apps to help with contact tracing. Will the strategy work?

Ventilator use atrophies the diaphragm, the muscle we use for breathing. The Lungpacer is designed to help coax it back to work, to enhance recovery.

Real estate investor Ani Sanyal and his partners are offering gallery space to local artists — for free — as part of a three-and-a-half-month artist-in-residence program.

The vaccine developed by the Plymouth Meeting firm and Wistar Institute researchers finished Phase I trials and is moving to an accelerated Phase II/III.

Adjuvants play a big role in many vaccines' effectiveness. Scientists say there needs to be more research into developing a variety of adjuvants because of their importance.